Prophylactic Effect of StrataXRT Gel on Radiation Therapy Induced Dermatitis
Phase 3
Recruiting
- Conditions
- Radiation Induced Dermatitis in Breast Cancer.
- Registration Number
- IRCT20181030041507N1
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
All patients with newly diagnosed breast cancer undergoing radical mastectomy and candidate for radiation therapy.
Signing the informed consent form.
No contraindication for radiotherapy.
Three weeks after chemotherapy.
Not receiving simultaneously chemotherapy and Herceptin.
Exclusion Criteria
All patients with history of radiation therapy of breast.
A history of systemic or cutaneous diseases such as diabetes mellitus or collagen vascular disease, and concomitant use of wound healing drugs such as systemic steroids.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ow Grade Skin Inflammatory Changes. Timepoint: Weekly. Method of measurement: Direct Observation and Transparent Sheet.
- Secondary Outcome Measures
Name Time Method Efficacy of StrataXRT gel. Timepoint: Weekly. Method of measurement: Examining the patient's medical records.